via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC:KALY) (“KALY”) has recently launched a line of CBD infused candies under the brand name Hemp4mula. KALY owns a U.S. Patented Cannabis Extraction Process and is developing cannabis extracts targeting $170 billion in therapies for specific health conditions. KALY’s pharmaceutical mission is augmented by KALY’s non-pharmaceutical CBD infused product development and sales. In addition to Hemp4mula, KALY recently announced its CBD infused sunscreen, HempTantation. KALY’s Hemp4mula CBD Gum went on sale on www.USMJ.com just last month and sales are booming. The www.USMJ.com website comes from North American Cannabis Holdings, Inc (USOTC:USMJ). Hemp4mula Gummies are expected to be for sale soon on www.USMJ.com. KALY management is targeting $1 million in sales in 2019 from its non-pharmaceutical CBD products. CBD sales market wide are anticipated to reach $22 billion in the next three years.
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company’s actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.